Al Janaby, T. (2025) “Co-expression of HER2/EGFRvIII/CD44 and Claudin 18.2/CD109 as Novel Prognostic Indicators in Stomach Adenocarcinoma”, World Journal of Oncology [Preprint]. doi:10.14740/wjon2552.